Combining urinary eosinophil-derived neurotoxin (EDN) and osteopontin resulted in a sensitivity of 72% and specificity of 95% to distinguish ovarian cancer from normal controls and elevation in early-stage ovarian cancer [135]. The gene discussed is RNASE2; the disease is ovarian cancer.